Remarkably, the expression of WTAP increased in gliomas with higher malignancy, such as higher WHO grade, IDH-wildtype, and molecular subgroups with poorer survival, in both tow datasets (Additional file 1: Fig. S1C). The gene discussed is WTAP; the disease is central nervous system cancer.